Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 47
dc.coverage.spatialGinebraen_US
dc.date.accessioned2015-12-26T01:42:51Z
dc.date.available2015-12-26T01:42:51Z
dc.date.issued1994
dc.identifier.govdocA47/51
dc.identifier.urihttps://apps.who.int/iris/handle/10665/203631
dc.language.isoesen_US
dc.publisherOrganización Mundial de la Saluden_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshDrug Industryen_US
dc.subject.meshMarketingen_US
dc.subject.meshEthics, Pharmacyen_US
dc.subject.meshHealth Planningen_US
dc.subject.meshHealth Policyen_US
dc.subject.meshWorld Health Organizationen_US
dc.subject.meshQuality Controlen_US
dc.titleTercer informe de la Comisión A (‎proyecto)‎en_US
dc.typeGoverning body documentsen_US
dc.subject.meshqualifierethicsen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record